The Largest Segment Driving The Growth Of Protein A Resin Market
 |
| Protein A Resin Market |
The global Protein A Resin Market is estimated to be valued at US$ 656.9 Mn in 2023 and is expected to exhibit a CAGR of 8.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Protein A resin is used to purify monoclonal antibodies (mAbs) from cell culture media. It works by binding the Fc region of antibodies through its affinity for IgG subclasses. This enables the simple and efficient purification of monoclonal and polyclonal antibodies from various samples.
Market key trends:
One of the major trends in the Protein A resin market is the rising demand for monoclonal antibodies. With increasing approvals and launches of monoclonal antibodies for various therapeutic areas such as oncology, autoimmune diseases, and others, the demand for Protein A resin for purification of these biologics is also growing substantially. Furthermore, advancements in affinity resins with better yield, purity and lifetime are also fueling the market growth. Various players are investing heavily in development of protein A resins with more reliability, flexibility and efficiency to meet the burgeoning requirements of biopharmaceutical industry.
SWOT Analysis
Strength: Protein A resin is widely used in antibody purification process as it has high specificity and affinity towards immunoglobulin G antibodies. It has high loading and binding capacity.
Weakness: Protein A resin is an expensive chromatography medium that increases the overall production costs for therapeutic antibodies. Frequent column cleaning and resin regeneration is required.
Opportunity: Growing biopharmaceutical industry and increasing demand for monoclonal antibody production is driving the demand for Protein A resin. Rise in chronic diseases is fueling the clinical research activities.
Threats: Alternative technologies for antibody purification like Protein L and Protein A/G are capturing some market share. Trade barriers and stringent regulatory guidelines can restrain the market growth.
Key Takeaways
The Global Protein A Resin Market Growth is expected to witness high, exhibiting a CAGR of 8.5% over the forecast period, due to increasing demand for monoclonal antibodies. Monoclonal antibodies have wide therapeutic applications in treating various chronic diseases like cancer, cardiovascular disorders, autoimmune diseases etc. This is fueling the need for large scale production of recombinant therapeutic antibodies which drives the Protein A Resin market.
Regional analysis: North America dominates the global Protein A Resin market owing to developed biopharmaceutical industry, heavy investments in R&D and increasing prevalence of chronic diseases in the region. Asia Pacific is expected to witness fastest growth during the forecast period supported by rising pharmaceutical production, improving healthcare infrastructure and growing awareness.
Key players operating in the Protein A Resin market are GE Healthcare, Thermo Fisher Scientific, Repligen, Tosoh Bioscience, EMD Millipore, Novasep, GenScript Biotech Corporation, Purolite Life Sciences, and Expedeon Ltd. Protein A resin from GE Healthcare dominates the market due to its wide application in purification of IgG class antibodies. Other players are focusing on developing integrated purification solutions and expanding production capacities to cater to the growing demand.
Comments
Post a Comment